Novartis AG

Type: Company
Name: Novartis AG
Nationality: Switzerland
Web Address: http://www.novartis.com
Fact Sheet: Fact Sheet for Novartis India Ltd
First reported 15 hours ago - Updated 19 mins ago - 24 reports

GSK and Novartis deal 'shows focus'

Earlier this week, two giants of the pharmaceutical industry Novartis and GlaxoSmithKline (GSK) struck a multi-billion-dollar deal to join forces and reshape their businesses.The deal involves swapping assets and combining their consumer health units ... [Published BBC - 19 mins ago]
First reported Apr 22 2014 - Updated 8 hours ago - 6 reports

US group buys Novartis animal health unit for about $5.4bn

, 2:04 pmUS pharmaceutical company Eli Lilly and Company is set to take over the animal health division of Novartis, which includes the fish health unit Novartis Aqua, for about $5.4 billion.The acquisition is part of a multi-billion overhaul of Novartis’ ... [Published Undercurrent News - 13 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 4 reports

Array Biopharma Announces Binimetinib Continues to Advance in Clinical Development

Following the recent announcement by Novartis and GlaxoSmithKline that they have entered into a definitive agreement to exchange certain assets, Array BioPharma Inc. (NASDAQ: ARRY) reports that Novartis has indicated that it will continue to honor its ... [Published Benzinga.com - 9 hours ago]
First reported Apr 22 2014 - Updated 13 hours ago - 6 reports

Novartis, Valeant bids herald new deal-making era for pharma

Novartis (NOVN.VX) and GlaxoSmithKline (GSK.L) agreed to trade more than $20 billion (11 billion pounds) worth of assets, boosting Novartis' cancer-drug business and Glaxo's vaccines business. Valeant Pharmaceuticals (VRX.TO) made a $47 billion unsolicited ... [Published NewsRT.co.uk - 23 hours ago]
First reported Apr 22 2014 - Updated 15 hours ago - 33 reports

Novartis hails transformative impact of new GlaxoSmithKline deal

:04 in Pharmaceutical Company Restructures Novartis has hailed the potentially transformative impact the transactions it announced with GlaxoSmithKline this week will have on its business. The companies signed a series of deals that will see Novartis ... [Published Zenopa - 15 hours ago]
First reported Apr 22 2014 - Updated 21 hours ago - 326 reports

Region’s drug firms can learn from big link-up

YORKSHIRE companies who focus on specialised drug production should be able to benefit from the latest round of consolidation in the global pharmaceuticals industry, it was claimed yesterday.Professor Christopher Bovis, of Hull University Business School, ... [Published Yorkshire Post - 21 hours ago]
First reported Apr 22 2014 - Updated 21 hours ago - 36 reports

Lilly to form world′s second largest animal health company through Novartis Animal Health purchase

eva gonzálezIndianapolis (USA)2014/04/22Novartis Animal Health is present approximately 40 countries and declared 2013 revenue at around $1.1Bn. Novartis Animal Health is focused on developing better ways to prevent and treat diseases in pets, farm animals ... [Published Eastwind - 21 hours ago]
First reported Apr 22 2014 - Updated 22 hours ago - 5 reports

Novartis Cancer Move Adds Spice to Rivalry with Roche

Sitting just two miles apart onopposite banks of the Rhine river in Basel , Switzerland , Novartis AG (NOVN) and Roche Holding AG (ROG) have long had a complexcrosstown rivalry. It’s just gotten more so.Novartis’s planned acquisition of GlaxoSmithKline ... [Published Bloomberg - 22 hours ago]
First reported Apr 23 2014 - Updated 22 hours ago - 3 reports

Lilly to Pay $5.4 Billion for Novartis Animal-Health Unit

Related Biotechnology, Pharmaceutical and Healthcare NewsDrug maker Eli Lilly is making a bet on rising global demand for animal drugs and vaccines with a deal to acquire Novartis AG's animal-health business for $5.4 billion.Original Article: NEXT ARTICLE ... [Published BioPortfolio - 22 hours ago]
First reported Apr 22 2014 - Updated Apr 22 2014 - 10 reports

Valeant Offer Leaves Allergan Investors Wanting More: Real M

(For a Real M&A column news alert: SALT REALMNA GO.) April 22 (Bloomberg) -- Valeant Pharmaceuticals International Inc.’s bid for Allergan Inc. gives the maker of Botox a valuation it hasn’t had since early 2008 -- and investors still expect more.Allergan ... [Published Washington Post - Apr 22 2014]
First reported Apr 22 2014 - Updated Apr 22 2014 - 5 reports

Novartis CEO says bolt-on buys still possible

ZURICH (Reuters) - Novartis will focus on completing the overhaul of its portfolio, but remains on the lookout for bolt-on buys that could strengthen its three core businesses, the drugmaker's ... ... [Published Big News Network - Apr 22 2014]
Entities: Novartis AG
First reported Apr 22 2014 - Updated Apr 22 2014 - 4 reports

Novartis Overhauls Product Portfolio

ZURICH—Novartis AG unveiled Tuesday a sweeping overhaul of its product portfolio, selling several units and buying another in a series of transactions valued at more than $25 billion. Basel-based Novartis said it is acquiring the oncology unit of Britain's ... [Published Atlanta Journal And Constitution - Apr 22 2014]

Quotes

...Units and Director of the Department of Medicine at Hebrew University-Hadassah Medical Center in Jerusalem, Israel, will present a poster titled: "A novel method for anti-TNF based-oral immunotherapy: Oral administration of a plant cell-expressed recombinant anti-TNF fusion protein for treating Crohn's disease." The poster which was accepted as late breaking research, will be presented on Tuesday, May 6 from 8:00 AM to 5:00 PM, Central Daylight Time, in the in...
"Rocky Mount's new laboratory, coupled with our investments throughout the plant, will help ensure that we continue to supply high-quality, more affordable medicines to customers and patients who need them" said Marty Nealey, Vice President of Hospira’s Rocky Mount Operations
According to the news reporters, the research concluded: "Adding ZOL to adjuvant therapy improved BMD, reduced BTM levels, and was well tolerated in premenopausal women with early HR+ BC receiving adjuvant chemotherapy and/or endocrine therapy."
...Brown . "I look forward to working with Alexza's talented employees to continue the transition from a development stage company to commercial stage company."

More Content

All (3820) | News (3351) | Reports (0) | Blogs (393) | Audio/Video (5) | Fact Sheets (32) | Press Releases (29)
sort by: Date | Relevance
Ramsay founder admitted to hospital [Published Eureka Report - 13 mins ago]
GSK and Novartis deal 'shows focus' [Published BBC - 19 mins ago]
EXELON (Rivastigmine Tartrate) Capsule EXELON (... [Published DailyMed Drug Label Updates for the last seven ... - 23 mins ago]
Cartoon: Preview awkwardness [Published Daily Princetonian - 40 mins ago]
VIDEO: GSK and Novartis deal 'shows focus' [Published BBC News Video - Business - 1 hour ago]
Novartis Signs Deals With GlaxoSmithKline & Eli... [Published DailyMe.Com - 1 hour ago]
Third Needle Found In Novartis Japan Voltaren S... [Published BioPortfolio - 1 hour ago]
Lawmakers discuss disposal [Published WRAL - 2 hours ago]
Inside Track: Behind the scenes of the Pfizer a... [Published City A.M. - 2 hours ago]
Horizon receives takeover offer [Published Eureka Report - 2 hours ago]
Array Biopharma Announces Binimetinib Continues... [Published BioMedReports - 2 hours ago]
Quality by Design - A Thriving Life Science Sec... [Published Citybizlist - 3 hours ago]
Studies from Novartis Animal Health Have Provid... [Published 4 Traders - 3 hours ago]
Allergan adopts poison pill to stall Valeant bid [Published Globe and Mail - 3 hours ago]
ALEXZA PHARMACEUTICALS : Winston R. Brown, Jr. ... [Published 4 Traders - 3 hours ago]
Patent Application Titled "Liquid Pharmaceutica... [Published 4 Traders - 3 hours ago]
Weebly raises $35m – Investment Round Up [Published Red Herring - 4 hours ago]
Array BioPharma To Report Financial Results For... [Published KLTV 7 - 4 hours ago]
Array BioPharma To Report Financial Results For... [Published TickerTech.com - 4 hours ago]
Apple earnings to steer stocks in Thursday's trade [Published CNBC - 4 hours ago]
Novartis GlaxoSmithKline Exchange Boosts Both C... [Published BioPortfolio - 4 hours ago]
GSK and Novartis join forces to create company ... [Published Pharmacy.Biz - 5 hours ago]
Best Of FORBES: Amazon-HBO Deal And Should Amge... [Published Forbes.com - 5 hours ago]
Stocks rally with upbeat mood [Published Dhaka Tribune - 5 hours ago]
Results show favorable impact of renal denervat... [Published Orthopedics Today - 6 hours ago]
BioNJ : Human Resource Conference on Culture Co... [Published 4 Traders - 6 hours ago]
Model N Announces Vertical Applications to Unif... [Published PRWeb - 6 hours ago]
Pharma giants sign healthcare deal [Published Laboratorytalk - 6 hours ago]
Diversity List Honors 21 Manufacturers, Led by ... [Published Industry Week - 6 hours ago]
Blockbuster Trades Are Changing The Face Of Pha... [Published WNYC - 6 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
EXELON (Rivastigmine Tartrate) Capsule EXELON (... [Published DailyMed Drug Label Updates for the last seven ... - 23 mins ago]
Updated Date: Apr 21, 2014 EST ...
VIDEO: GSK and Novartis deal 'shows focus' [Published BBC News Video - Business - 1 hour ago]
Keith Lostaglio of consultants A T Kearney tells the BBC what is behind GlaxoSmithKline and Novartis's deal. ...
Binimetinib Continues To Advance In Clinical De... [Published PR Newswire: Health - 9 hours ago]
BOULDER, Colo., April 23, 2014 /PRNewswire/ -- Following the recent announcement by Novartis and GlaxoSmithKline that they have entered into a definitive agreement to exchange certain assets, Array BioPharma Inc. (NASDAQ: ARRY) reports that Novartis ...
Ex-dividends drag FTSE 100 down [Published Proactiveinvestors United Kingdom website - 10 hours ago]
Britain’s blue chip index retreated from two-week highs on Wednesday as a number of stocks went ‘ex-dividend’, meaning they traded without the right to their latest dividend. Antofagasta ( LON:ANTO ) finished 5.7% lower, British Gas group Centrica ...
GSK, Novartis in transformational three-step deal [Published BvDEP Zephyr Editorial News - 12 hours ago]
GlaxoSmithKline (GSK) has entered into oncology, vaccines and consumer healthcare deals with Novartis as the two pharmaceutical juggernauts seek to drive sustainable sales growth and boost long-term earnings.... ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Big pharma braces for M&A wave [Published Reuters Video: Business - Apr 22 2014]
Novartis And GlaxoSmithKline Doing Deals [Published Wall Street Journal What's News - Apr 22 2014]
Novartis CEO: Revamp leaves us "fighting fit" [Published Reuters Video: Top News - Apr 22 2014]
Novartis CEO: Revamp leaves us "fighting fit" [Published Reuters Video: Business - Apr 22 2014]
Novartis reviews business but not rewards [Published Reuters Video: Business - Jan 29 2014]
1

Press Releases

sort by: Date | Relevance
Fitch: Novartis/GSK Deal Highlights Narrowing R... [Published Fitch Ratings Headlines Corporate - 14 hours ago]
Equities to Watch in the Health Care Sector -- ... [Published Financial Services - Apr 09 2014]
Senior Notes Conversions, FDA Drug Approvals, A... [Published Financial Services - Apr 03 2014]
Health Care Sector Equities Technical Commentar... [Published Financial Services - Mar 21 2014]
Key Pharmaceutical Executive Joins Mesoblast [Published GlobeNewswire: Acquisitions News - Mar 11 2014]
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.